The Gut Microbiome and Metabolic Syndrome

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2019 Oct 2

PMID 31573550

Citations 307

Authors

Kruttika Dabke

Gustaf Hendrick

Suzanne Devkota

Affiliations

Soon will be listed here.

Abstract

The metabolic syndrome (MetS) is a constellation of risk factors that, if left untreated, will often progress to greater metabolic defects such as type 2 diabetes and nonalcoholic fatty liver disease. While these risk factors have been established for over 40 years, the definition of MetS warrants reconsideration in light of the substantial data that have emerged from studies of the gut microbiome. In this Review we present the existing recent literature that supports the gut microbiome's potential influence on the various risk factors of MetS. The interplay of the intestinal microbiota with host metabolism has been shown to be mediated by a myriad of factors, including a defective gut barrier, bile acid metabolism, antibiotic use, and the pleiotropic effects of microbially produced metabolites. These data show that events that start in the gut, often in response to external cues such as diet and circadian disruption, have far-reaching effects beyond the gut.

Citing Articles

The joint and interactive effects of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and body mass index on the risk of depression, as well as the mediating role of NHHR: results from NHANES 2005-2023.

Zhang L, Lai Y, Yan L, Fang J, Wang K Lipids Health Dis. 2025; 24(1):77.

PMID: 40022090 PMC: 11869543. DOI: 10.1186/s12944-025-02493-x.

Fecal Short-Chain Fatty Acids Are Associated with Obesity in Gestational Diabetes.

Molan K, Ambrozic Avgustin J, Likar M, Pongrac Barlovic D, Zgur Bertok D, Starcic Erjavec M Biomedicines. 2025; 13(2).

PMID: 40002799 PMC: 11853429. DOI: 10.3390/biomedicines13020387.

Analysis of influencing factors of washed microbiota transplantation in treating patients with metabolic syndrome.

Lin D, Hu D, Wu Q, Huang L, Lin Z, Xu J Front Nutr. 2025; 12:1508381.

PMID: 39963663 PMC: 11830617. DOI: 10.3389/fnut.2025.1508381.

Integrative analysis of intestinal flora and untargeted metabolomics in attention-deficit/hyperactivity disorder.

Lu J, Jiang M, Chai D, Sun Y, Wu L Front Microbiol. 2025; 16:1452423.

PMID: 39944648 PMC: 11817268. DOI: 10.3389/fmicb.2025.1452423.

Chylomicron Characteristics Are Associated With Microsomal Triglyceride Transfer Protein in an Animal Model of Diet-Induced Dysbiosis.

Olano C, Farina G, Wiszniewski M, Medel J, Morales C, Friedman S J Lipid Atheroscler. 2025; 14(1):106-119.

PMID: 39911957 PMC: 11791422. DOI: 10.12997/jla.2025.14.1.106.

References

Saklayen M . The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018; 20(2):12. PMC: 5866840. DOI: 10.1007/s11906-018-0812-z. View

Yassour M, Lim M, Yun H, Tickle T, Sung J, Song Y . Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes. Genome Med. 2016; 8(1):17. PMC: 4756455. DOI: 10.1186/s13073-016-0271-6. View

Sarafidis P, Nilsson P . The metabolic syndrome: a glance at its history. J Hypertens. 2006; 24(4):621-6. DOI: 10.1097/01.hjh.0000217840.26971.b6. View

Cai D, Yuan M, Frantz D, Melendez P, Hansen L, Lee J . Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 2005; 11(2):183-90. PMC: 1440292. DOI: 10.1038/nm1166. View

Wan Y, Wang F, Yuan J, Li J, Jiang D, Zhang J . Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial. Gut. 2019; 68(8):1417-1429. DOI: 10.1136/gutjnl-2018-317609. View

Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S . Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019; 25(7):1096-1103. PMC: 6699990. DOI: 10.1038/s41591-019-0495-2. View

Skurk T, Alberti-Huber C, Herder C, Hauner H . Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab. 2006; 92(3):1023-33. DOI: 10.1210/jc.2006-1055. View

Chambers E, Viardot A, Psichas A, Morrison D, Murphy K, Zac-Varghese S . Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2014; 64(11):1744-54. PMC: 4680171. DOI: 10.1136/gutjnl-2014-307913. View

Turnbaugh P, Ley R, Mahowald M, Magrini V, Mardis E, Gordon J . An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444(7122):1027-31. DOI: 10.1038/nature05414. View

10.

Zambell K, Fitch M, Fleming S . Acetate and butyrate are the major substrates for de novo lipogenesis in rat colonic epithelial cells. J Nutr. 2003; 133(11):3509-15. DOI: 10.1093/jn/133.11.3509. View

11.

Vrieze A, van Nood E, Holleman F, Salojarvi J, Kootte R, Bartelsman J . Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012; 143(4):913-6.e7. DOI: 10.1053/j.gastro.2012.06.031. View

12.

de la Cuesta-Zuluaga J, Mueller N, Corrales-Agudelo V, Velasquez-Mejia E, Carmona J, Abad J . Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut. Diabetes Care. 2016; 40(1):54-62. DOI: 10.2337/dc16-1324. View

13.

Chassaing B, Van de Wiele T, De Bodt J, Marzorati M, Gewirtz A . Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017; 66(8):1414-1427. PMC: 5940336. DOI: 10.1136/gutjnl-2016-313099. View

14.

Matey-Hernandez M, Williams F, Potter T, Valdes A, Spector T, Menni C . Genetic and microbiome influence on lipid metabolism and dyslipidemia. Physiol Genomics. 2018; 50(2):117-126. PMC: 5867613. DOI: 10.1152/physiolgenomics.00053.2017. View

15.

Fujisaka S, Ussar S, Clish C, Devkota S, Dreyfuss J, Sakaguchi M . Antibiotic effects on gut microbiota and metabolism are host dependent. J Clin Invest. 2016; 126(12):4430-4443. PMC: 5127688. DOI: 10.1172/JCI86674. View

16.

Backhed F, Ding H, Wang T, Hooper L, Koh G, Nagy A . The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004; 101(44):15718-23. PMC: 524219. DOI: 10.1073/pnas.0407076101. View

17.

Wang Y, Kuang Z, Yu X, Ruhn K, Kubo M, Hooper L . The intestinal microbiota regulates body composition through NFIL and the circadian clock. Science. 2017; 357(6354):912-916. PMC: 5702268. DOI: 10.1126/science.aan0677. View

18.

Brown J, Hazen S . The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu Rev Med. 2015; 66:343-59. PMC: 4456003. DOI: 10.1146/annurev-med-060513-093205. View

19.

Xiao H, Sun Z, Zhang H, Zhang D . Berberine inhibits dyslipidemia in C57BL/6 mice with lipopolysaccharide induced inflammation. Pharmacol Rep. 2012; 64(4):889-95. DOI: 10.1016/s1734-1140(12)70883-6. View

20.

Mukherji A, Kobiita A, Ye T, Chambon P . Homeostasis in intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs. Cell. 2013; 153(4):812-27. DOI: 10.1016/j.cell.2013.04.020. View